Talphera (TLPH) News Today $0.50 0.00 (-0.85%) Closing price 05/27/2025 03:55 PM EasternExtended Trading$0.51 +0.01 (+1.06%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Talphera (NASDAQ:TLPH) Stock Price Up 0.4% - Here's WhyMay 24, 2025 | americanbankingnews.comTalphera, Inc.: Talphera Announces First Quarter 2025 Financial Results and Provides Corporate UpdateMay 17, 2025 | finanznachrichten.deEarnings call transcript: Talphera Inc. outlines strategic shifts in Q1 2025May 16, 2025 | uk.investing.comTalphera, Inc. (NASDAQ:TLPH) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comTalphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financingMay 15, 2025 | msn.comTalphera, Inc. (TLPH) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comTalphera Announces First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | prnewswire.comTalphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025May 7, 2025 | prnewswire.comAll You Need to Know About Talphera (TLPH) Rating Upgrade to Strong BuyMay 7, 2025 | msn.comTalphera (TLPH) Upgraded to Buy: What Does It Mean for the Stock?April 5, 2025 | msn.comTalphera reports Q4 EPS (7c) vs. (25c) last yearApril 1, 2025 | markets.businessinsider.comTalphera, Inc. (NASDAQ:TLPH) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comTalphera announces agreement with FDA to reduce NEPHRO CRRT study sizeApril 1, 2025 | markets.businessinsider.comTalphera Reports 2024 Financial Results and Study UpdateMarch 31, 2025 | tipranks.comTalphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of NiyadMarch 31, 2025 | msn.comTalphera, Inc. (TLPH) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comTalphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 31, 2025 | prnewswire.comTalphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 MillionMarch 31, 2025 | prnewswire.com7TLPH : Earnings Outlook For TalpheraMarch 28, 2025 | benzinga.comTalphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025March 26, 2025 | prnewswire.comTalphera initiated with a Buy at Rodman & RenshawJanuary 28, 2025 | markets.businessinsider.comRodman & Renshaw sets Talphera stock Buy rating, $4 targetJanuary 28, 2025 | msn.comBuy Rating Affirmed for Talphera: Strategic Adjustments and Valuation Strengthen Investment CaseJanuary 21, 2025 | markets.businessinsider.comTalphera reaches agreement with FDA in Nephro CRRT studyJanuary 15, 2025 | markets.businessinsider.comTalphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT StudyJanuary 14, 2025 | prnewswire.comTalphera’s Promising Prospects: Buy Rating Affirmed Amidst Strategic Advancements in Anticoagulant DevelopmentNovember 16, 2024 | markets.businessinsider.comTalphera, Inc.: Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 16, 2024 | finanznachrichten.deOptimistic Buy Rating for Talphera Driven by Promising NEPHRO CRRT Study Progress and Niyad’s PotentialNovember 15, 2024 | markets.businessinsider.comTalphera, Inc. (NASDAQ:TLPH) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comTalphera Reports Q3 2024 Results and Study ProgressNovember 14, 2024 | markets.businessinsider.comTalphera, Inc. (TLPH) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comTalphera Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 13, 2024 | prnewswire.comAn Overview of Talphera's EarningsNovember 12, 2024 | benzinga.comTalphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024November 6, 2024 | prnewswire.comMarinus downgraded after setback to late-stage trialOctober 25, 2024 | msn.comTalphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 8, 2024 | prnewswire.comTalphera to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 5, 2024 | prnewswire.comTalphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal CircuitAugust 19, 2024 | prnewswire.comBullish Outlook on Talphera’s Niyad: Phase 3 Trial Advancements and Market Potential Justify Buy RatingAugust 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Talphera Amid Strategic Advancements in NEPHRO CRRT StudyAugust 15, 2024 | markets.businessinsider.comTalphera, Inc. (TLPH) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comTalphera, Inc.: Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 15, 2024 | finanznachrichten.deTalphera: Q2 Earnings SnapshotAugust 15, 2024 | sfgate.comTalphera, Inc. (NASDAQ:TLPH) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comTLPH Stock Earnings: Talphera Beats EPS for Q2 2024August 15, 2024 | markets.businessinsider.comTalphera Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | prnewswire.comTalphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024August 5, 2024 | prnewswire.comTalphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 20, 2024 | prnewswire.comTalphera, Inc. (NASDAQ:TLPH) Q1 2024 Earnings Call TranscriptMay 17, 2024 | msn.comOptimistic Buy Rating for Talphera Despite Phase 3 Trial Enrollment DelayMay 16, 2024 | markets.businessinsider.com Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address TLPH Media Mentions By Week TLPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLPH News Sentiment▼0.941.03▲Average Medical News Sentiment TLPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLPH Articles This Week▼21▲TLPH Articles Average Week Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kronos Bio News Rani Therapeutics News Atara Biotherapeutics News Iterum Therapeutics News Lantern Pharma News Spero Therapeutics News Pluri News Oncolytics Biotech News Eliem Therapeutics News Reviva Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLPH) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
